Literature DB >> 6203331

Evidence of persistent IgA/IgG circulating immune complexes associated with activation of the complement system in serum of a patient with common variable immune deficiency: anaphylactic reactions to intravenous gammaglobulin.

V Wahn, R A Good, S Gupta, S Pahwa, N K Day.   

Abstract

A 44 year old woman with common variable immunodeficiency developed severe anaphylactic reactions to intravenous gammaglobulin. Analysis of her serum prior to the infusion of gammaglobulin was thus analyzed and the tests revealed a complete absence of free IgA, presence of an IgG autoantibody to IgA, IgA-IgG circulating immune complexes, and depressed levels of hemolytic C3 associated with elevated levels of C3a and C3d. The IgA-IgG complexes did not clear from the circulation even after six months following cessation of gammaglobulin infusions. Analysis of the complexes isolated by sucrose density gradient ultracentrifugation showed that they bind to solid phase F(ab')2 anti-C1q, have a high molecular weight (greater than 19s), activate the complement (C) system via the classical pathway in vitro and are comprised of IgG and IgA. These data suggest that in this patient an autoantibody response to IgA was probably associated with persistent endogenous production of IgA yielding IgG-IgA circulating immune complexes and activation of the complement system. Although the patient has no free IgA and no surface IgA bearing B cells, her peripheral blood lymphocytes were shown to contain cells capable of secreting IgA. Low levels of IgM and IgG were detectable in her serum, and B cells bearing surface IgM, IgG and IgD were present in normal numbers in the blood.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6203331

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand Suppl        ISSN: 0108-0172


  5 in total

Review 1.  Intravenous immunoglobulin in immunodeficiency states: state of the art.

Authors:  Elias Toubi; Amos Etzioni
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

2.  Home intravenous immunoglobulin therapy by self-administration.

Authors:  E R Ashida; A Saxon
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

3.  Dietary bovine antigens and immune complex formation after intravenous immunoglobulin in common varied immunodeficiency.

Authors:  C Cunningham-Rundles; R I Carr
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

4.  Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies.

Authors:  J Björkander; L Hammarström; C I Smith; R H Buckley; C Cunningham-Rundles; L A Hanson
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

5.  Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.

Authors:  Kenji Satake; Yoshio Shimizu; Yohei Sasaki; Hiroyuki Yanagawa; Hitoshi Suzuki; Yusuke Suzuki; Satoshi Horikoshi; Shinichiro Honda; Kazuko Shibuya; Akira Shibuya; Yasuhiko Tomino
Journal:  BMC Nephrol       Date:  2014-06-13       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.